Sapient

About:

Biomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.

Website: https://www.sapient.bio

Twitter/X: SapientBio

Top Investors: Bill & Melinda Gates Foundation

Description:

Sapient enables the discovery of circulating small molecule biomarkers at unprecedented speed and scale. Leveraging next-generation mass spectrometry, biocomputational analysis, and large-scale human biology databases, its platform supports the rapid identification and validation of circulating biomarkers of health, disease, and drug response which are needed to align patients, disease biology, and specific therapies.